封面
市场调查报告书
商品编码
1740967

医疗保健咨询服务市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

Healthcare Consulting Services Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

出版日期: | 出版商: Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024年,全球医疗保健咨询服务市场规模达280亿美元,预计到2034年将以9.1%的复合年增长率成长,达到669亿美元。这得归功于医疗保健机构对优化营运、整合新技术和提升病患治疗效果日益增长的需求。随着全球医疗保健系统面临提高效率、采用数位化解决方案和遵守监管要求的挑战,对专业医疗保健咨询服务的需求预计将大幅增长。

医疗保健咨询服务市场 - IMG1

医疗保健产业持续的数位转型、提升营运效率的需求、日益复杂的监管环境以及对以患者为中心的医疗服务的日益重视,是推动医疗保健咨询服务需求成长的关键因素。包括医院、保险公司和製药公司在内的医疗保健机构正在寻求技术整合、营运优化、法规合规性和策略规划等领域的专业知识。随着医疗保健产业的不断发展,顾问公司正在帮助这些机构应对复杂的挑战,提供创新的解决方案,并确保其永续发展。

市场范围
起始年份 2024
预测年份 2025-2034
起始值 280亿美元
预测值 669亿美元
复合年增长率 9.1%

根据服务类型,策略咨询细分市场在2024年的估值为71亿美元,预计成长势头强劲,到2034年将达到168亿美元,复合年增长率达9%,这主要受多种因素驱动,包括技术的快速进步、患者人口结构的变化以及监管环境的不断演变。此外,疫情后的復苏加速了医疗机构对创新解决方案的需求。策略咨询公司正致力于开发新的框架和策略,以帮助医疗服务提供者应对这一动态环境。

根据最终用途,医疗保健咨询服务市场中的医疗保健提供者细分市场在2024年占了28.2%的份额。医疗保健提供者利用咨询服务来改善患者护理、优化医院管理并实现成本节约。顾问协助医疗保健提供者实施最佳实践、采用新技术、改善营运工作流程并遵守法规变更。在该领域使用咨询服务可确保提供者能够适应不断变化的医疗保健服务格局。

2024年,北美医疗保健咨询服务市场占据43.3%的市场份额,这得益于市场对技术整合和营运咨询服务的强劲需求。北美预计将主导医疗保健咨询服务市场,这得益于其强大的医疗保健基础设施、对数位医疗保健解决方案的持续投资以及对提高医疗保健服务效率的日益重视。美国在医疗保健创新领域处于领先地位,医疗保健提供者、保险公司和製药公司正在增加对咨询服务的投资,以改善医疗保健效果、降低成本并整合新技术。

全球医疗咨询服务业的知名企业包括:普华永道、贝恩公司、Cognizant、麦肯锡公司、波士顿顾问集团、HURON、德勤、NTT DATA、奥纬咨询、IQVIA、安永、艾意凯、埃森哲。为了巩固市场地位,领先的顾问公司正在采取多项关键策略,包括与医疗服务提供者建立策略合作伙伴关係,以了解他们独特的挑战和需求。许多公司利用人工智慧和资料分析等先进技术,提供数据驱动的洞察,从而改善营运。此外,专注于医疗领域的利基市场,例如远距医疗和数位健康解决方案,使他们能够提供差异化服务。

目录

第一章:方法论与范围

第二章:执行摘要

第三章:行业洞察

  • 产业生态系统分析
  • 产业衝击力
    • 成长动力
      • 医疗保健领域的技术进步
      • 併购活动增加
      • 全球研发支出不断增加
    • 产业陷阱与挑战
      • 隐性成本和营运动态
  • 成长潜力分析
  • 监管格局
  • 川普政府关税
    • 对贸易的影响
      • 贸易量中断
      • 报復措施
    • 对产业的影响
      • 供应方影响(原料)
        • 主要材料价格波动
        • 供应链重组
        • 生产成本影响
      • 需求面影响(售价)
        • 价格传导至终端市场
        • 市占率动态
        • 消费者反应模式
    • 受影响的主要公司
    • 策略产业反应
      • 供应链重组
      • 定价和产品策略
      • 政策参与
    • 展望与未来考虑
  • 技术格局
  • 未来市场趋势
  • 波特的分析
  • PESTEL分析
  • 监管格局

第四章:竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 策略仪表板

第五章:市场估计与预测:按服务类型,2021 - 2034 年

  • 主要趋势
  • IT咨询
  • 数位咨询
  • 营运咨询
  • 策略咨询
  • 财务咨询
  • 其他服务类型

第六章:市场估计与预测:依最终用途,2021 - 2034 年

  • 主要趋势
  • 医疗保健提供者
  • 医疗保健付款人
  • 生命科学和製药公司
  • 政府和监管机构
  • 医疗科技和数位健康公司

第七章:市场估计与预测:按地区,2021 - 2034 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第八章:公司简介

  • Accenture
  • Bain & Company
  • BCG
  • Cognizant
  • Deloitte
  • EY
  • HURON
  • IQVIA
  • LEK
  • McKinsey & Company
  • NTT DATA
  • Oliver Wyman
  • PwC
简介目录
Product Code: 9947

The Global Healthcare Consulting Services Market was valued at USD 28 billion in 2024 and is estimated to grow at a CAGR of 9.1% to reach USD 66.9 billion by 2034, driven by the increasing demand for healthcare organizations to optimize operations, integrate new technologies, and enhance patient outcomes. As healthcare systems worldwide face the challenges of improving efficiency, adopting digital solutions, and complying with regulatory requirements, the need for specialized healthcare consulting services is expected to expand significantly.

Healthcare Consulting Services Market - IMG1

The ongoing digital transformation in the healthcare industry, the need to improve operational efficiencies, the rise in regulatory complexities, and the increasing focus on patient-centric care are key factors driving the demand for healthcare consulting services. Healthcare organizations, including hospitals, insurance companies, and pharmaceutical companies, are seeking expertise in areas such as technology integration, operational optimization, regulatory compliance, and strategic planning. As the healthcare sector continues to evolve, consulting firms are helping these organizations navigate complex challenges, providing innovative solutions, and ensuring sustainable growth.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$28 Billion
Forecast Value$66.9 Billion
CAGR9.1%

Based on service type, the strategy consulting segment was valued at USD 7.1 billion in 2024, with projections indicating a strong growth trajectory, reaching USD 16.8 billion by 2034, reflecting a CAGR of 9% driven by multiple factors, including rapid technological advancements, changing patient demographics, and the evolving regulatory landscape. In addition, the post-pandemic recovery has accelerated the demand for innovative solutions within healthcare organizations. Strategy consulting firms are focusing on developing new frameworks and strategies to help healthcare providers navigate this dynamic environment.

Based on end use, the healthcare providers segment from the healthcare consulting services market held a 28.2% share in 2024. Healthcare providers use consulting services to improve patient care, optimize hospital administration, and achieve cost savings. Consultants assist healthcare providers in implementing best practices, adopting new technologies, improving operational workflows, and staying compliant with regulatory changes. The use of consulting services in this sector ensures that providers can adapt to the ever-changing landscape of healthcare delivery.

North America Healthcare Consulting Services Market held a 43.3% share in 2024, supported by strong market demand for technology integration and operational consulting services. North America is expected to dominate the healthcare consulting services market, driven by the robust healthcare infrastructure, ongoing investments in digital healthcare solutions, and an increasing focus on improving healthcare delivery efficiency. U.S. is a leader in healthcare innovation, with healthcare providers, insurers, and pharmaceutical companies increasingly investing in consulting services to improve healthcare outcomes, reduce costs, and integrate new technologies.

Prominent players in the Global Healthcare Consulting Services Industry include: PwC, Bain & Company, Cognizant, McKinsey & Company, BCG, HURON, Deloitte, NTT DATA, Oliver Wyman, IQVIA, EY, LEK, Accenture. To strengthen their market presence, leading consulting firms are adopting several key strategies. These include strategic partnerships with healthcare providers to understand their unique challenges and needs. Many firms leverage advanced technologies like artificial intelligence and data analytics to deliver data-driven insights for operational improvements. Additionally, focusing on niche markets within healthcare, such as telemedicine and digital health solutions, allows them to differentiate their services.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Technological advancements in the healthcare sector
      • 3.2.1.2 Increased mergers and acquisitions activity
      • 3.2.1.3 Rising global spending on research and development
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Hidden costs and operational dynamics
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Trump administration tariffs
    • 3.5.1 Impact on trade
      • 3.5.1.1 Trade volume disruptions
      • 3.5.1.2 Retaliatory measures
    • 3.5.2 Impact on the Industry
      • 3.5.2.1 Supply-side impact (raw materials)
        • 3.5.2.1.1 Price volatility in key materials
        • 3.5.2.1.2 Supply chain restructuring
        • 3.5.2.1.3 Production cost implications
      • 3.5.2.2 Demand-side impact (selling price)
        • 3.5.2.2.1 Price transmission to end markets
        • 3.5.2.2.2 Market share dynamics
        • 3.5.2.2.3 Consumer response patterns
    • 3.5.3 Key companies impacted
    • 3.5.4 Strategic industry responses
      • 3.5.4.1 Supply chain reconfiguration
      • 3.5.4.2 Pricing and product strategies
      • 3.5.4.3 Policy engagement
    • 3.5.5 Outlook and future considerations
  • 3.6 Technology landscape
  • 3.7 Future market trends
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis
  • 3.10 Regulatory landscape

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Service Type, 2021 - 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 IT consulting
  • 5.3 Digital consulting
  • 5.4 Operations consulting
  • 5.5 Strategy consulting
  • 5.6 Financial consulting
  • 5.7 Other service types

Chapter 6 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Healthcare providers
  • 6.3 Healthcare payers
  • 6.4 Lifescience and pharma companies
  • 6.5 Government and regulatory agencies
  • 6.6 Healthcare technology and digital health companies

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Spain
    • 7.3.5 Italy
    • 7.3.6 Netherlands
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
  • 7.6 Middle East and Africa
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia
    • 7.6.3 UAE

Chapter 8 Company Profiles

  • 8.1 Accenture
  • 8.2 Bain & Company
  • 8.3 BCG
  • 8.4 Cognizant
  • 8.5 Deloitte
  • 8.6 EY
  • 8.7 HURON
  • 8.8 IQVIA
  • 8.9 LEK
  • 8.10 McKinsey & Company
  • 8.11 NTT DATA
  • 8.12 Oliver Wyman
  • 8.13 PwC